While the mechanisms underlying rhodopsin-related retinal dystrophy have been systemically reviewed previously (Athanasiou et al., 2018), here, we focus more on well-studies mechanisms that have been utilized for the development of potential therapeutic approaches. This evidence concerns the gene RHO and Retinal dystrophy.